IRIS UniCatt

Caira, Morena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.512
NA - Nord America 2.653
AS - Asia 1.877
SA - Sud America 318
AF - Africa 39
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.408
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.599
DE - Germania 1.917
SG - Singapore 876
CN - Cina 616
SE - Svezia 362
UA - Ucraina 330
BR - Brasile 257
FR - Francia 156
PL - Polonia 154
GB - Regno Unito 143
IT - Italia 141
IE - Irlanda 108
FI - Finlandia 69
ID - Indonesia 68
IN - India 68
RU - Federazione Russa 64
VN - Vietnam 63
TR - Turchia 44
MX - Messico 31
AR - Argentina 29
IQ - Iraq 24
BD - Bangladesh 20
JP - Giappone 19
CA - Canada 16
HK - Hong Kong 15
ZA - Sudafrica 13
BE - Belgio 11
NL - Olanda 11
ES - Italia 9
SA - Arabia Saudita 9
EC - Ecuador 8
PK - Pakistan 8
UZ - Uzbekistan 8
VE - Venezuela 7
CO - Colombia 6
KE - Kenya 6
KZ - Kazakistan 6
AU - Australia 5
CI - Costa d'Avorio 5
CL - Cile 5
AL - Albania 4
AT - Austria 4
EG - Egitto 4
HU - Ungheria 4
IL - Israele 4
LT - Lituania 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
JO - Giordania 3
KR - Corea 3
MA - Marocco 3
MD - Moldavia 3
NG - Nigeria 3
PH - Filippine 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
IR - Iran 2
MY - Malesia 2
NZ - Nuova Zelanda 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CG - Congo 1
DZ - Algeria 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
ME - Montenegro 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
Totale 8.408
Salva come PNG Salva come JPEG
Città #
Chandler 474
Singapore 372
Ashburn 258
Jacksonville 196
Warsaw 147
San Mateo 145
Nürnberg 120
Dublin 107
Ann Arbor 102
Beijing 94
Dearborn 94
Nanjing 91
Woodbridge 76
New York 72
Wilmington 72
Jakarta 64
Bremen 63
Lawrence 56
Boston 52
Hefei 50
Houston 50
Los Angeles 47
Munich 47
Moscow 42
Milan 40
Nanchang 40
Zhengzhou 39
Izmir 34
Seattle 32
Fairfield 31
Buffalo 30
Marseille 30
São Paulo 27
Lancaster 25
Kunming 24
Frankfurt am Main 23
Ho Chi Minh City 23
University Park 22
Hebei 20
Tianjin 20
Shenyang 19
Hanoi 18
Redwood City 18
Mountain View 17
Shanghai 16
Boardman 15
Hong Kong 15
Jiaxing 15
Changsha 14
Cuauhtémoc 14
Kent 14
Philadelphia 14
Leawood 12
Rome 12
Tokyo 12
Brussels 11
Cambridge 10
Guangzhou 10
Hangzhou 10
Pune 10
Fremont 9
Porto Alegre 9
Auburn Hills 8
Baghdad 8
Santa Clara 8
Chicago 7
Costa Mesa 7
Düsseldorf 7
Kraków 7
Mexico City 7
Norwalk 7
Nuremberg 7
Princeton 7
Rio de Janeiro 7
Cattolica 6
Dallas 6
London 6
Phoenix 6
Tashkent 6
Toronto 6
Abidjan 5
Amsterdam 5
Augusta 5
Belo Horizonte 5
Brooklyn 5
Campinas 5
Indiana 5
Jinan 5
Nairobi 5
Riyadh 5
Salvador 5
San Francisco 5
Taizhou 5
Almaty 4
Brasília 4
Budapest 4
Charlotte 4
Contursi Terme 4
Curitiba 4
Guarulhos 4
Totale 3.861
Salva come PNG Salva come JPEG
Nome #
Incidence of acute myeloid leukemia after breast cancer 363
Factors associated with mortality in bacteremic patients with hematologic malignancies. 345
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 334
A prospective survey of febrile events in hematological malignancies 289
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 205
Factors associated with mortality in bacteremic patients with hematologic malignancies. 205
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 187
Increased production of gliotoxin is related to the formation of biofilm byAspergillus fumigatus: an immunological approach 182
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 181
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 174
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 174
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 166
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 149
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 144
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 144
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 143
A prospective survey of febrile events in hematological malignancies 138
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 135
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 133
A prospective survey of febrile events in hematological malignancies 132
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 132
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 131
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 131
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 130
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 129
Advanced mast cell disease: an Italian Hematological Multicenter experience. 128
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 128
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 128
A patient with acute myeloid leukemia and a solid mass in the colon. 123
Uncommon yeast infections in hematological patients: from diagnosis to treatment 120
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 120
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 115
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 115
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 112
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 111
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 107
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 105
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 103
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 103
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 101
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 101
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 100
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 100
The role of primary antifungal prophylaxis in patients with haematological malignancies 100
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 99
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 99
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 95
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 90
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 89
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 89
Invasive fungal infections in patients with acute myeloid leukcemia and in those submitted to allogenic hemopoietic stem cell transplant: Who is at highest risk?. 88
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 86
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 82
. Pulmonary aspergillosis: lights and shadows 78
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 78
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 73
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 70
The management of febrile neutropenia in the posaconazole era: a new challenge? 62
Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends 59
Italian Hema e-Chart Group.Continuous surveillance of invasive fungal infection: a realistic goal for the near future. 59
Risks for infection in patients with myelodysplasia and acute leukemia 56
Uncommon yeast infections in hematological patients: from diagnosis to treatment 53
Totale 8.438
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.411
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.411
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021371 0 0 0 0 0 38 89 16 74 18 126 10
2021/2022561 72 60 7 24 16 11 13 86 25 42 71 134
2022/20231.207 123 174 109 224 92 163 45 104 138 5 25 5
2023/2024439 32 155 6 8 14 70 33 8 4 9 62 38
2024/2025934 40 36 67 15 104 32 15 43 190 69 169 154
2025/20261.359 386 61 132 205 458 117 0 0 0 0 0 0
Totale 8.438